<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">J Speech Lang Hear Res</journal-id>
<journal-id journal-id-type="iso-abbrev">J. Speech Lang. Hear. Res</journal-id>
<journal-id journal-id-type="publisher-id">JSLHR</journal-id>
<journal-title-group>
<journal-title>Journal of Speech, Language, and Hearing Research : JSLHR</journal-title>
</journal-title-group>
<issn pub-type="ppub">1092-4388</issn>
<issn pub-type="epub">1558-9102</issn>
<publisher>
<publisher-name>American Speech-Language-Hearing Association</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">28586922</article-id>
<article-id pub-id-type="pmc">5544413</article-id>
<article-id pub-id-type="publisher-id">10924388006000061606</article-id>
<article-id pub-id-type="doi">10.1044/2016_JSLHR-L-15-0358</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Language</subject>
<subj-group subj-group-type="heading">
<subject>Research Articles</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Noncomprehension Signaling in Males and Females With Fragile X Syndrome</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Thurman</surname>
<given-names>Angela John</given-names>
</name>
<xref ref-type="aff" rid="aff1">a</xref>
<xref ref-type="aff" rid="aff2">b</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Kover</surname>
<given-names>Sara T.</given-names>
</name>
<xref ref-type="aff" rid="aff3">c</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Ted Brown</surname>
<given-names>W.</given-names>
</name>
<xref ref-type="aff" rid="aff4">d</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Harvey</surname>
<given-names>Danielle J.</given-names>
</name>
<xref ref-type="aff" rid="aff5">e</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Abbeduto</surname>
<given-names>Leonard</given-names>
</name>
<xref ref-type="aff" rid="aff1">a</xref>
<xref ref-type="aff" rid="aff2">b</xref>
</contrib>
</contrib-group>
<aff id="aff1"><label>a</label>MIND Institute, University of California Davis, Sacramento</aff>
<aff id="aff2"><label>b</label>Department of Psychiatry and Behavioral Sciences, University of California Davis, Sacramento</aff>
<aff id="aff3"><label>c</label>Department of Speech and Hearing Sciences, University of Washington, Seattle</aff>
<aff id="aff4"><label>d</label>New York State Institute for Basic Research in Developmental Disabilities, Staten Island</aff>
<aff id="aff5"><label>e</label>Department of Public Health Sciences, University of California Davis</aff>
<author-notes>
<fn>
<p>
<bold><italic>Disclosure:</italic></bold>
<italic>The authors have declared that no competing interests existed at the time of publication.</italic>
</p>
</fn>
<corresp id="cor1">Correspondence to Angela John Thurman: <email>ajthurman@ucdavis.edu</email></corresp>
<fn>
<p>Editor: Rhea Paul</p>
</fn>
<fn>
<p>Associate Editor: Sarita Eisenberg</p>
</fn>
</author-notes>
<pub-date pub-type="ppub">
<month>6</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="epub">
<day>10</day>
<month>6</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>1</day>
<month>12</month>
<year>2017</year>
</pub-date>
<!-- PMC Release delay is 6 months and
						0 days and was based on the <pub-date
						pub-type="ppub"/>. -->
<volume>60</volume>
<issue>6</issue>
<fpage>1606</fpage>
<lpage>1621</lpage>
<history>
<date date-type="received">
<day>15</day>
<month>10</month>
<year>2015</year>
</date>
<date date-type="rev-recd">
<day>10</day>
<month>6</month>
<year>2016</year>
</date>
<date date-type="accepted">
<day>05</day>
<month>12</month>
<year>2016</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright © 2017 American Speech-Language-Hearing Association</copyright-statement>
</permissions>
<self-uri xlink:href="JSLHR-60-1606.pdf" xlink:title="pdf"></self-uri>
<abstract>
<sec>
<title>Purpose</title>
<p>This study used a prospective longitudinal design to evaluate the trajectory and predictors of noncomprehension signaling in male and female youth with fragile X syndrome (FXS).</p>
</sec>
<sec>
<title>Method</title>
<p>A direction-following task in which some of the directions were inadequate was administered. Participants were 52 youth (36 boys, 16 girls) with FXS. Upon study entry, participants ranged from 10 to 16 years. The average number of annual assessments per participant was 3.65 (range = 1–4), providing 198 data points for analysis.</p>
</sec>
<sec>
<title>Results</title>
<p>Participants with FXS were less likely to signal noncomprehension than younger, typically developing, cognitively matched children. The average rate of change in noncomprehension signaling was not significantly different from 0 for either boys or girls, suggesting a plateau. Both FMRP and nonverbal IQ were significant independent predictors of noncomprehension signaling for boys. Variability in noncomprehension signaling among girls was not explained by any of the predictors, but trends similar to those observed for boys were observed.</p>
</sec>
<sec>
<title>Conclusions</title>
<p>Noncomprehension signaling appears to be an area of weakness for individuals with FXS. Because the failure to signal noncomprehension can have negative, cumulative effects on comprehension, the results suggest a need for interventions targeting the requisite cognitive skills.</p>
</sec>
</abstract>
<funding-group>
<funding-statement>This research was supported by Grant R01HD024356 (awarded to Leonard Abbeduto) and by the MIND Institute Intellectual and Developmental Disabilities Research Center (U54 HD079125, awarded to Leonard Abbeduto), both funded by the National Institute of Child Health and Human Development. Note that Leonard Abbeduto has received financial support to develop and implement outcome measures for clinical trials from F. Hoffman-LaRoche Ltd., Roche TCRC, Inc., and Neuren Pharmaceuticals Ltd. No other authors have financial disclosures to make.</funding-statement>
</funding-group>
<counts>
<page-count count="16"></page-count>
</counts>
</article-meta>
</front>
</article>
</pmc-articleset>